For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #179
Wednesday 14 September 2022, 12:43 AM

[Image: micheile dot com on Unsplash]
“Low serotonin not the cause of depression”
Following a review paper on the relationship between serotonin and depression,1 the lead author Joanna Moncrieff, a psychiatry professor at University
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. go.nature.com/3R5lUQv (Moncrieff J, et al. Mol Psychiatry, 2022).
2. bit.ly/3TbmIVw (UCL, ScienceDaily, 20 July).